Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva J Gordon

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
ACS Chemical Biology|January 25, 2007
Small-molecule screening: it takes a villageEva J Gordon
Clinical Breast Cancer|May 14, 2013
Intraductal therapy of ductal carcinoma in situ: a presurgery studyM Ellen Mahoney, Eva J Gordon, Jian Yu Rao, et al.
Case Reports in Oncology|July 20, 2018
Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung CancerEva J Gordon, David Parker, Kelly Barth, et al.
Chemistry & Biology|May 26, 2004
Synthetic glycoprotein mimics inhibit L-selectin-mediated rolling and promote L-selectin sheddingPatricia Mowery, Zhi-Qiang Yang, Eva J Gordon, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 22, 2012
A feasibility study of the intraductal administration of chemotherapySusan M Love, Wei Zhang, Eva J Gordon, et al.
Frontiers in Oncology|May 15, 2023
Case Report: Long-term complete response to PSMA-targeted radioligand therapy and abiraterone in a metastatic prostate cancer patientDavid Parker, Jessica Zambelli, Montana Kay Lara, et al.
Frontiers in Oncology|February 26, 2024
<i>ERBB2</i> (HER2) amplifications and co-occurring <i>KRAS</i> alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibitionAfsaneh Barzi, Caroline M Weipert, Carin R Espenschied, et al.
Plos One|April 14, 2016
Examination of Duct Physiology in the Human Mammary GlandDixie Mills, Ameer Gomberawalla, Eva J Gordon, et al.
Journal of Physiology and Biochemistry|October 11, 2011
The physiology of the normal human breast: an exploratory studyDixie Mills, Eva J Gordon, Ashley Casano, et al.
Frontiers in Oncology|January 19, 2024
Case report: <i>ex vivo</i> tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinomaMarwah Al-Aloosi, Amanda M Prechtl, Payel Chatterjee, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
ACS Chemical Biology|January 25, 2007
Small-molecule screening: it takes a villageEva J Gordon
Clinical Breast Cancer|May 14, 2013
Intraductal therapy of ductal carcinoma in situ: a presurgery studyM Ellen Mahoney, Eva J Gordon, Jian Yu Rao, et al.
Case Reports in Oncology|July 20, 2018
Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung CancerEva J Gordon, David Parker, Kelly Barth, et al.
Chemistry & Biology|May 26, 2004
Synthetic glycoprotein mimics inhibit L-selectin-mediated rolling and promote L-selectin sheddingPatricia Mowery, Zhi-Qiang Yang, Eva J Gordon, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 22, 2012
A feasibility study of the intraductal administration of chemotherapySusan M Love, Wei Zhang, Eva J Gordon, et al.
Frontiers in Oncology|May 15, 2023
Case Report: Long-term complete response to PSMA-targeted radioligand therapy and abiraterone in a metastatic prostate cancer patientDavid Parker, Jessica Zambelli, Montana Kay Lara, et al.
Frontiers in Oncology|February 26, 2024
<i>ERBB2</i> (HER2) amplifications and co-occurring <i>KRAS</i> alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibitionAfsaneh Barzi, Caroline M Weipert, Carin R Espenschied, et al.
Plos One|April 14, 2016
Examination of Duct Physiology in the Human Mammary GlandDixie Mills, Ameer Gomberawalla, Eva J Gordon, et al.
Journal of Physiology and Biochemistry|October 11, 2011
The physiology of the normal human breast: an exploratory studyDixie Mills, Eva J Gordon, Ashley Casano, et al.
Frontiers in Oncology|January 19, 2024
Case report: <i>ex vivo</i> tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinomaMarwah Al-Aloosi, Amanda M Prechtl, Payel Chatterjee, et al.
Pageof 1